Medical Technology Group

The Medical Technology Group (MTG) is a not for profit organisation in the United Kingdom comprising patient groups, research charities and medical device manufacturers. Its stated aim is to "work together to improve patient access to effective medical technologies". The Group launched in 2000.

Current members of the MTG are:

In June 2016, the Medical Technology Group published its report 'Déjà Review - what lessons can be learned from the past?'. The report identified 17 different organisations or initiatives that have been launched with the aim of promoting innovation in the NHS over the previous ten years. In Déjà Review, the MTG noted that the NHS has historically and consistently failed to apply any learnings from the previous reviews, including 2011’s much-quoted Innovation, Health and Wealth (IHW).

In 2015 the Medical Technology Group contacted every acute Trust and Clinical Commissioning Group in England to identify the level of unplanned or emergency hospital admissions for urology, diabetes and heart failure. The research found that unplanned and emergency hospital admissions account for more than a third of all hospital admissions - 5.4 million in total - and two thirds of all hospital bed days. It also found that the NHS spent £434 million in 2013/14 treating over 180,000 hospital patients with an unplanned admission for a urinary tract infection; unplanned admissions owing to diabetic complications cost over £200 million each year. Additional findings were that each NHS Trust handles on average over 100 deaths each year from congestive heart failure, but with regional differences in approach and success rates: for example 66% of presenting heart patients in the Southwest were treated in hospital compared to just 16% in the West Midlands.

In June 2015 the MTG published its review of the 2011 Innovation, Health & Wealth report by NHS Improvement & Efficiency, Innovation and Service Improvement. The Scorecard reviewed progress against the six areas identified by the NHS as those where Clinical Commissioning Groups and acute Trusts could improve patient care through high impact innovations. The report revealed a very mixed picture, with both CCGs and Trusts in some areas performing much worse than others, and some regions of the country drastically underperforming.

Following a Freedom of Information request to all NHS Acute Trusts in England, in September 2014 the MTG published a report: Infection Prevention and Control – Combatting a problem that has not gone away that revealed that the majority of Trusts were unaware of the full scale or the operational and financial impact of five common infections: sepsis; catheter-associated urinary tract infections; catheter-related blood infections; ventilator-associated pneumonia; and norovirus. The MTG called on the Government to develop a strategy for using technology for infection prevention and control.

...
Wikipedia